The GeneSight test analyzes clinically important genetic variations in your DNA. The results of the test can inform your doctor about genes that may impact how you metabolize or respond to certain ...

“The HAM-D6 scale has been shown to be a better measure of core depressive symptoms than the HAM-D17 scale,” said Boadie W. Dunlop, M.D., one of the study investigators and associate professor of ...

Myriad Genetics, through its Assurex Health subsidiary, said today it will partner with the U.S. Department of Veterans Affairs to assess the company's GeneSight ® genetic test in veterans diagnosed ...

Medication failure leads 45% of respondents with depression and/or anxiety to turn to unhealthy coping mechanisms From restricted or binge eating to excessive gambling to extreme social media use, 77% ...

SALT LAKE CITY, June 08, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today a newly published study in Psychiatry ...

SALT LAKE CITY, July 01, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced the launch of a new patient home ...

SALT LAKE CITY, April 30, 2025 (GLOBE NEWSWIRE) -- Nearly nine out of ten (89%) Americans diagnosed with depression and/or anxiety believe mental health medications are somewhat or very effective, yet ...

SALT LAKE CITY, November 16, 2020 - A new nationwide poll, the GeneSight Mental Health Monitor, shows that nearly two-thirds (61%) of Americans age 65 or older who have concerns about having ...

Educated guesses — totally acceptable for trivia nights. But for prescribing medications? Less than ideal. Well, the sad truth is that’s been psychiatrists’ only real technique to decide how to treat ...

SALT LAKE CITY, April 19, 2023 (GLOBE NEWSWIRE) -- From restricted or binge eating to excessive gambling to extreme social media use, 77% of Americans surveyed say they have used at least one ...